Alseres Pharmaceuticals Financial Statements
Alseres Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
This data is provided as per license from EDGAR Online
Alseres Pharmaceuticals Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (18.9) | (26.4) | (11.6) |
| Total Net Income ($ mil.) | (19.5) | (26.4) | (11.5) |
| Diluted EPS (Net Income) | (1.04) | (1.59) | (1.03) |
Alseres Pharmaceuticals Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (4.9) | (5.1) | (4.5) |
| Total Net Income ($ mil.) | (5.3) | (5.4) | (4.7) |
| Diluted EPS (Net Income) | (0.26) | (0.27) | (0.22) |
Alseres Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | -- | 3.75 | 1.56 |
| Price/Earnings Ratio | -- | 16.34 | 15.82 |
| Price/Book Ratio | -- | 2.92 | 1.52 |
| Price/Cash Flow Ratio | -- | 13.17 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Alseres Pharmaceuticals Financial Ratios
Alseres Pharmaceuticals Competitive Intelligence
| Acorda Therapeutics | Cephalon | GE Healthcare Bio-Sciences | |
|---|---|---|---|
| Annual Sales ($ mil.) | 39.5 | 1,772.6 | 3,000.0 |
| Employees | -- | 2,796 | -- |
| Market Cap ($ mil.) | 945.7 | 5,325.5 | -- |
Competitive Landscape
